Articles dans des revues avec comité de lecture (51)
  1. 9. Wauthoz, N., Rosiere, R., & Amighi, K. (2020). Inhaled cytotoxic chemotherapy: clinical challenges, recent developments, and future prospects. Expert opinion on drug delivery. doi:10.1080/17425247.2021.1829590
  2. 10. Nieto-Orellana, A., Li, H., Rosiere, R., Wauthoz, N., Williams, H., Monteiro, C. J., Bosquillon, C., Childerhouse, N., Keegan, G., Coghlan, D., Mantovani, G., & Stolnik, S. (2019). Targeted PEG-poly(glutamic acid) complexes for inhalation protein delivery to the lung. Journal of controlled release, 316, 250-262. doi:10.1016/j.jconrel.2019.10.012
  3. 11. Rosiere, R., Berghmans, T., De Vuyst, P., Amighi, K., & Wauthoz, N. (2019). The position of inhaled chemotherapy in the care of patients with lung tumours: clinical feasibility and indications according to recent pharmaceutical progresses. Cancers, 11(329), 1-13. doi:10.3390/cancers11030329
  4. 12. Albertini, B., Mathieu, V., Iraci, N., Van Woensel, M., Schoubben, A., Donnadio, A., Greco, S., Ricci, M., Temperini, A., Blasi, P., & Wauthoz, N. (2019). Tumor Targeting by Peptide-Decorated Gold Nanoparticles. Molecular pharmaceutics, 16(6), 2430-2444. doi:10.1021/acs.molpharmaceut.9b00047
  5. 13. Salade, L., Wauthoz, N., Goole, J., & Amighi, K. (2019). How to characterize a nasal product. The state of the art of in vitro and ex vivo specific methods. International journal of pharmaceutics, 561, 47-65. doi:10.1016/j.ijpharm.2019.02.026
  6. 14. Wauthoz, N., Hennia, I., Ecenarro, S., & Amighi, K. (2018). Impact of capsule type on aerodynamic performance of inhalation products: A case study using a formoterol-lactose binary or ternary blend. International journal of pharmaceutics, 553(1-2), 47-56. doi:10.1016/j.ijpharm.2018.10.034
  7. 15. Wauthoz, N., Hennia, I., Ecenarro, S., & Amighi, K. (2018). Impact of capsule type on aerodynamic performance of inhalation products: A case study using a formoterol-lactose binary or ternary blend. International journal of pharmaceutics, 553(1-2), 47-56. doi:10.1016/j.ijpharm.2018.10.034
  8. 16. Salade, L., Wauthoz, N., Vermeersch, M., Amighi, K., & Goole, J. (2018). Chitosan-coated liposome dry-powder formulations loaded with ghrelin for nose-to-brain delivery. European journal of pharmaceutics and biopharmaceutics, 129, 257-266. doi:10.1016/j.ejpb.2018.06.011
  9. 17. Rosiere, R., Hureaux, J., Levet, V., Amighi, K., & Wauthoz, N. (2018). La chimiothérapie inhalée – partie 1 : concept et challenges technologiques actuels. Revue des maladies respiratoires, 35(4), 357-377. doi:10.1016/j.rmr.2018.02.001
  10. 18. Rosiere, R., Hureaux, J., Levet, V., Amighi, K., & Wauthoz, N. (2018). La chimiothérapie inhalée – partie 2 : clinique et applications potentielles. Revue des maladies respiratoires, 35(4), 378-389. doi:10.1016/j.rmr.2018.02.002
  11. 19. Rosiere, R., Van Woensel, M., Gelbcke, M., Mathieu, V., Hecq, J., Mathivet, T., Vermeersch, M., Van Antwerpen, P., Amighi, K., & Wauthoz, N. (2018). New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation. Molecular pharmaceutics, 15(3), 899-910. doi:10.1021/acs.molpharmaceut.7b00846
  12. 20. Salade, L., Wauthoz, N., Deleu, M., Vermeersch, M., De Vriese, C., Amighi, K., & Goole, J. (2017). Development of coated liposomes loaded with ghrelin for nose-to-brain delivery for the treatment of cachexia. International Journal of Nanomedicine (Online), 12, 8531—8543. doi:10.2147/IJN.S147650
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 Suivant >>